Envision reaches contract agreement with Cigna

Envision Healthcare has reached a new statewide agreement with Cigna Healthcare of Arizona. The multiyear agreement ensures Envision’s clinicians are in-network.

The new contract comes at a time with Envision is facing contract tensions with another health insurance provider, UnitedHealthcare.

Nashville, Tennessee-based Envision delivers physician services in more than 1,800 clinical departments in healthcare facilities in 45 states, with approximately 2,000 physicians and advanced practice clinicians in Arizona alone. The company has received some criticism for its billing practices recently, including its emergency room practices, which UnitedHealthcare has called “egregious.”

Envision has since launched two education campaigns to give consumers more information about surprise billing and to finalize a contract with UnitedHealthcare. UnitedHealthcare warned Envision in September that it could drop the physician services provider from its network.

In Arizona, Envision physicians practice at hospitals within the Banner Health, Dignity Health and HonorHealth systems.

“Envision’s clinicians have been serving our community for years in our local hospitals and ambulatory surgery centers,” said Kim Shepard, Market President for Cigna in Arizona. “Our new network agreement will help make it easier for our customers, and we are pleased to build upon our collaboration to improve the health and well-being of the thousands of Cigna members who rely on Envision's services.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.